Skip to main content
Erschienen in: International Ophthalmology 6/2019

18.06.2018 | Original Paper

Outer nuclear layer thickness at the central fovea relation with symptom duration in central serous chorioretinopathy

verfasst von: Ibrahim Ozdemir, Ayla Eren, Giray Ersöz

Erschienen in: International Ophthalmology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate a relation between the outer nuclear layer (ONL) thickness and symptom duration in patients with central serous chorioretinopathy (CSC) using spectraldomain optical coherence tomography (SDOCT) and to compare with healthy subjects.

Methods

This retrospective study included 67 CSC patients and 20 healthy subjects. The ONL thickness was measured between internal limiting membrane and external limiting membrane at central fovea using SD-OCT (Topcon 3D OCT-2000, Japan). The patients were divided into six groups based on symptom duration: group (1) contained 14 patients (symptom duration between 1 and 30 days) , group (2) contained 11 patients (symptom duration between 31 and 60 days), group (3) contained 12 patients (symptom duration between 61 and 90 days) , group (4) contained 11 (symptom duration between 91 and 120 days), group (5) contained 7 patients (symptom duration between 121 and 150 days) and group (6) contained 12 (symptom duration between 151 days and more).

Results

The average ONL thickness was 76.1 ± 16.8 μm in CSC in all patients and 122.4 ± 2.8 μm in healthy subjects. The major differences were between group (3) and (4) (p < 0.001). The ONL thickness was negatively correlated with symptom duration (rs = − 0.918; p< 0.001). In addition, the ONL thickness was positively correlated with BCVA (rs = 0.619; p< 0.001).

Conclusion

Photoreceptor loss could begin within the first 3 months in CSC.
Literatur
1.
Zurück zum Zitat Iida T, Hagimura N, Sato T, Kishi S (2000) Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol 129:16–20CrossRefPubMed Iida T, Hagimura N, Sato T, Kishi S (2000) Evaluation of central serous chorioretinopathy with optical coherence tomography. Am J Ophthalmol 129:16–20CrossRefPubMed
2.
Zurück zum Zitat Behar-Cohen F, Zhao M (2016) Corticosteroids and the retina: a role for the mineralocorticoid receptor. Curr Opin Neurol 29:49–54CrossRefPubMed Behar-Cohen F, Zhao M (2016) Corticosteroids and the retina: a role for the mineralocorticoid receptor. Curr Opin Neurol 29:49–54CrossRefPubMed
3.
Zurück zum Zitat Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496–500CrossRef Spaide RF, Koizumi H, Pozzoni MC (2008) Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146:496–500CrossRef
4.
Zurück zum Zitat Matsumoto H, Sato T, Kishi S (2009) Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol 148:105–110CrossRefPubMed Matsumoto H, Sato T, Kishi S (2009) Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. Am J Ophthalmol 148:105–110CrossRefPubMed
5.
Zurück zum Zitat Ojima Y, Hangai M, Sasahara M, Gotoh N, Inoue R, Yasuno Y, Makita S, Yatagai T, Tsujikawa A, Yoshimura N (2007) Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography. Ophthalmology 114:2197–2207CrossRefPubMed Ojima Y, Hangai M, Sasahara M, Gotoh N, Inoue R, Yasuno Y, Makita S, Yatagai T, Tsujikawa A, Yoshimura N (2007) Three-dimensional imaging of the foveal photoreceptor layer in central serous chorioretinopathy using high-speed optical coherence tomography. Ophthalmology 114:2197–2207CrossRefPubMed
6.
Zurück zum Zitat Piccolino FC, de la Longrais RR, Ravera G et al (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87–99CrossRefPubMed Piccolino FC, de la Longrais RR, Ravera G et al (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139:87–99CrossRefPubMed
7.
Zurück zum Zitat Wang MS, Sander B, Larsen M (2002) Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 133:787–793CrossRefPubMed Wang MS, Sander B, Larsen M (2002) Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 133:787–793CrossRefPubMed
8.
Zurück zum Zitat Eandi CM, Chung JE, Cardillo-Piccolino F, Spaide RF (2005) Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 25:417–421CrossRefPubMed Eandi CM, Chung JE, Cardillo-Piccolino F, Spaide RF (2005) Optical coherence tomography in unilateral resolved central serous chorioretinopathy. Retina 25:417–421CrossRefPubMed
9.
Zurück zum Zitat Schocket LS, Witkin AJ, Fujimoto JG et al (2006) Ultrahigh-resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair. Ophthalmology 113:666–672CrossRefPubMedPubMedCentral Schocket LS, Witkin AJ, Fujimoto JG et al (2006) Ultrahigh-resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair. Ophthalmology 113:666–672CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Drexler W, Sattmann H, Hermann B et al (2003) Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol 121:695–706CrossRefPubMed Drexler W, Sattmann H, Hermann B et al (2003) Enhanced visualization of macular pathology with the use of ultrahigh-resolution optical coherence tomography. Arch Ophthalmol 121:695–706CrossRefPubMed
11.
Zurück zum Zitat Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118CrossRef Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118CrossRef
12.
Zurück zum Zitat Verma L, Sinha R, Venkatesh P et al (2004) Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial. BMC Ophthalmol. 4:15CrossRefPubMedPubMedCentral Verma L, Sinha R, Venkatesh P et al (2004) Comparative evaluation of diode laser versus argon laser photocoagulation in patients with central serous retinopathy: a pilot, randomized controlled trial. BMC Ophthalmol. 4:15CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Chan WM, Lim T-H, Pece A et al (2010) Verteporfin PDT for non-standard indications a review of current literature. Graefes Arch Clin Exp Ophthalmol 248:613–626CrossRefPubMed Chan WM, Lim T-H, Pece A et al (2010) Verteporfin PDT for non-standard indications a review of current literature. Graefes Arch Clin Exp Ophthalmol 248:613–626CrossRefPubMed
14.
Zurück zum Zitat Cook B, Lewis GP, Fisher SK et al (1995) Apoptotic photoreceptordegeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci 36:990–996PubMed Cook B, Lewis GP, Fisher SK et al (1995) Apoptotic photoreceptordegeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci 36:990–996PubMed
15.
Zurück zum Zitat Hisatomi T, Sakamoto T, Goto Y et al (2002) Critical role of photoreceptor apoptosis in functional damage after retinal detachment. Curr Eye Res 41:1542–1545 Hisatomi T, Sakamoto T, Goto Y et al (2002) Critical role of photoreceptor apoptosis in functional damage after retinal detachment. Curr Eye Res 41:1542–1545
16.
Zurück zum Zitat Vogel RN, Langlo CS, Scoles D et al (2017) High-resolution imaging of intraretinal structures in active and resolved central serous chorioretinopathy. Invest Ophthalmol Vis Sci 58(1):42–49CrossRefPubMedPubMedCentral Vogel RN, Langlo CS, Scoles D et al (2017) High-resolution imaging of intraretinal structures in active and resolved central serous chorioretinopathy. Invest Ophthalmol Vis Sci 58(1):42–49CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149:361–363CrossRefPubMed Yannuzzi LA (2010) Central serous chorioretinopathy: a personal perspective. Am J Ophthalmol 149:361–363CrossRefPubMed
18.
Zurück zum Zitat Chan WM, Lam DSC, Lai TYY et al (2003) Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 136:836–845CrossRefPubMed Chan WM, Lam DSC, Lai TYY et al (2003) Treatment of choroidal neovascularization in central serous chorioretinopathy by photodynamic therapy with verteporfin. Am J Ophthalmol 136:836–845CrossRefPubMed
19.
Zurück zum Zitat Nicholson B, Noble J, Forooghian F, Meyerle C (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58:103–126CrossRefPubMedPubMedCentral Nicholson B, Noble J, Forooghian F, Meyerle C (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58:103–126CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 33:2096–2102CrossRefPubMed Bousquet E, Beydoun T, Zhao M, Hassan L, Offret O, Behar-Cohen F (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 33:2096–2102CrossRefPubMed
21.
Zurück zum Zitat Pichi F, Carrai P, Ciardella A, Behar-Cohen F, Nucci P (2016) Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy. Int Ophthalmol 16:377–382 Pichi F, Carrai P, Ciardella A, Behar-Cohen F, Nucci P (2016) Comparison of two mineralcorticosteroids receptor antagonists for the treatment of central serous chorioretinopathy. Int Ophthalmol 16:377–382
Metadaten
Titel
Outer nuclear layer thickness at the central fovea relation with symptom duration in central serous chorioretinopathy
verfasst von
Ibrahim Ozdemir
Ayla Eren
Giray Ersöz
Publikationsdatum
18.06.2018
Verlag
Springer Netherlands
Erschienen in
International Ophthalmology / Ausgabe 6/2019
Print ISSN: 0165-5701
Elektronische ISSN: 1573-2630
DOI
https://doi.org/10.1007/s10792-018-0950-y

Weitere Artikel der Ausgabe 6/2019

International Ophthalmology 6/2019 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Open Access 22.02.2024 | Peeling | Originalien

Selektive Vitalfarbstoffe in der Makulachirurgie

Erhöhen sie die Wahrscheinlichkeit der intraoperativen ILM-Identifizierung auch bei einem erfahrenen Operateur?

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.